Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (146)	10/19/1999 6:17:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 438

Biowa: Chuckle. Very good. Won't touch it, however. Apart from saying that Kent Johnson, CFO at PharMingen and a Harvard MBA, was capable of doing the work of any three men, and walking at the end of the day with a good attitude. Hey, if there are any VCs out there that are looking for bright, hard-working guys..... Kent Johnson, PharMingen (now a division of Becton Dickinson) CFO. Glenn Nedwin, too.... ex- of Genentech, Molecular Diagnostics (Bayer), Incyte's precursor (Ideon?), and XOMA....... last I heard he was CEO of Novo's industrial enzyme sub in Davis...... he's another candidate for best of class, and he's a Harvard MBA. Of course, the Ph.D. in Molecular Bio doesn't hurt. Jeff..... I feel that a discussion of a "given" educational background, in the context of management skill sets, is a big mistake. Quite impressed by Maderis thus far, and yesterday's deal is a windfall for GZMO. Henri is treating the sub just fine.